Home › Research › Lewy body dementia
Crucial role of microglia-mediated myelin sheath damage in vascular dementia: Antecedents and consequences
Qi Shao, Simin Chen, Yuxiao Zheng, Wen‐Xiu Xu, Jiahui Chen, Wei Dong Shao, Qingguo Wang, Changxiang Li et al.. Neural Regeneration Research, 2025-03-25
Topic: Brain proteins, microglia and lab models
Plain-language summary
Chronic cerebral hypoperfusion can lead to neuronal necrosis, trigger inflammatory responses, promote white matter damage, and ultimately result in cognitive impairment. Consequently, chronic cerebral hypoperfusion is an important factor influencing the onset and progression of vascular dementia. The myelin sheath is a critical component of white matter, and damage and repair of the white matter are closely linked to myelin sheath integrity. This article reviews the role of microglia in vascular dementia, focusing on their effects on myelin sheaths and the potential therapeutic implications. The findings suggest that ischemia and hypoxia cause disruption of the blood-brain barrier and activate microglia, which may worsen blood-brain barrier damage through the release of matrix-degrading enzymes. Microglia-mediated metabolic reprogramming is recognized as an important driver of inflammation. Damage to the blood-brain barrier and subsequent inflammation can lead to myelin injury and accelerate the progression of vascular dementia. Early activation of microglia is a protective response that contributes to the maintenance of blood-brain barrier integrity through sensing, debris-clearing, and defensive mechanisms. However, prolonged activation can trigger a shift in microglia toward the pro-inflammatory M1 phenotype, resulting in myelin damage and cognitive impairment. Triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells 1 have been identified as potential biomarkers for vascular dementia, as both are closely linked to cognitive decline. Although effective clinical treatments for myelin damage in the central nervous system are currently lacking, researchers are actively working to develop targeted therapies. Several drugs, including nimodipine, dopaminergic agents, simvastatin, biotin, and quetiapine, have been evaluated for clinical use in treating microglial and myelin damage. Future research will face challenges in developing targeted therapeutic strategies for vascular dementia, requiring further investigation into the timing, duration, and specific mechanisms of microglial activation, as well as the exploration of new drug combinations and additional therapeutic targets.
What this study adds
Evidence grade: Low
This review describes how chronic cerebral hypoperfusion activates microglia, which can damage the blood-brain barrier and myelin sheath and contribute to vascular dementia. It discusses potential therapeutic implications of targeting microglia, but does not report a tested treatment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Shao, Q., Chen, S., Zheng, Y., Xu, W., Chen, J., Shao, W. D., et al. (2025). Crucial role of microglia-mediated myelin sheath damage in vascular dementia: Antecedents and consequences. Neural Regeneration Research. https://doi.org/10.4103/nrr.nrr-d-24-01109
Vancouver
Shao Q, Chen S, Zheng Y, Xu W, Chen J, Shao WD, et al. Crucial role of microglia-mediated myelin sheath damage in vascular dementia: Antecedents and consequences. Neural Regeneration Research. 2025. doi:10.4103/nrr.nrr-d-24-01109. PMID: 40145953.
BibTeX
@article{shao2025-40145953,
author = {Shao, Qi and Chen, Simin and Zheng, Yuxiao and Xu, Wen‐Xiu and Chen, Jiahui and Shao, Wei Dong and Wang, Qingguo and Li, Changxiang and others},
title = {{Crucial role of microglia-mediated myelin sheath damage in vascular dementia: Antecedents and consequences}},
journal = {Neural Regeneration Research},
year = {2025},
doi = {10.4103/nrr.nrr-d-24-01109},
pmid = {40145953},
url = {https://doi.org/10.4103/nrr.nrr-d-24-01109}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Chronic cerebral hypoperfusion can lead to neuronal necrosis, trigger inflammatory responses, promote white matter damage, and ultimately result in cognitive impairment.
- The findings suggest that ischemia and hypoxia cause disruption of the blood-brain barrier and activate microglia, which may worsen blood-brain barrier damage through the release of matrix-degrading enzymes.
Why it matters
This review describes how chronic cerebral hypoperfusion activates microglia, which can damage the blood-brain barrier and myelin sheath and contribute to vascular dementia. It discusses potential therapeutic implications of targeting microglia, but does not report a tested treatment.
Study details
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neural Regeneration Research) |
| Journal's citation record | 1 / 4 | Neural Regeneration Research: journal h-index 100 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 17 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 5.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 17 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Xueqian Wang: h-index 13 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Beijing University of Chinese Medicine: institution h-index 298 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40145953) |
| Free to read | 2 / 2 | Free to read |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.4103/nrr.nrr-d-24-01109
- PubMed: 40145953
- Original source →
- Free full text: Neural Regeneration Research →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Lewy body dementia from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.